Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bonviva IV vs Alendronate Renal Safety Study
NCT00503113Phase 4Completed
- Sponsor
- Roche
- Start
- Jul 2007
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 4 trial of ibandronic acid in postmenopausal osteoporosis, sponsored by Roche. Started Jul 2007; status: completed.
02
Drugs
ibandronic acid
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00503113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00503113.